Biotest
BIO.F
HK$357.89
Share price
0.48%
Change (1 day)
2.11%
Change (1 year)
Categories
Revenue for Biotest (BIO.F)
Revenue in 2024 (TTM): HK$6.03 Billion
According to Biotest
's latest financial reports the company's current revenue (TTM 
) is HK$5.99 Billion. In 2023 the company made a revenue of HK$5.79 Billion an increase over the revenue in the year 2022 that were of HK$4.25 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Biotest from 2009 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 (TTM) | HK$6.03 B | 4.15% |
| 2023 | HK$5.79 B | 35.95% |
| 2022 | HK$4.25 B | -8.93% |
| 2021 | HK$4.67 B | 7.2% |
| 2020 | HK$4.36 B | 19.36% |
| 2019 | HK$3.65 B | -0.79% |
| 2018 | HK$3.68 B | 57.6% |
| 2017 | HK$2.33 B | -46.83% |
| 2016 | HK$4.39 B | -12.93% |
| 2015 | HK$5.05 B | -13.88% |
| 2014 | HK$5.86 B | 13.54% |
| 2013 | HK$5.16 B | 16.3% |
| 2012 | HK$4.44 B | -1.76% |
| 2011 | HK$4.52 B | 17.3% |
| 2010 | HK$3.85 B | -19.77% |
| 2009 | HK$4.80 B |